Thalidomide as an anti-TNF-alpha inhibitor: implications for clinical use

Clin Immunol Immunopathol. 1996 Dec;81(3):219-23. doi: 10.1006/clin.1996.0181.

Authors

J D Klausner¹, V H Freedman, G Kaplan

Affiliation

¹ Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021-6399, USA.

PMID: 8938097
DOI: 10.1006/clin.1996.0181

No abstract available

Publication types

Review

MeSH terms

Animals
Humans
Immunosuppressive Agents / pharmacology*
Thalidomide / pharmacology*
Thalidomide / therapeutic use*
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Immunosuppressive Agents
Tumor Necrosis Factor-alpha
Thalidomide